FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2970639571> ?p ?o ?g. }

• W2970639571 endingPage "101310" @default.
• W2970639571 startingPage "101310" @default.
• W2970639571 abstract "Multiple myeloma (MM), the second most common haematological malignancy, is a clonal plasma B-cell neoplasm that forms within the bone marrow. Despite recent advancements in treatment, MM remains an incurable disease. Auranofin, a linear gold(I) phosphine compound, has previously been shown to exert a significant anti-myeloma activity by inhibiting thioredoxin reductase (TrxR) activity. A bis-chelated tetrahedral gold(I) phosphine complex [Au(d2pype)2]Cl (where d2pype is 1,2-bis(di-2-pyridylphosphino)ethane) was previously designed to improve the gold(I) compound selectivity towards selenol- and thiol-containing proteins, such as TrxR. In this study, we show that [Au(d2pype)2]Cl significantly inhibited TrxR activity in both bortezomib-sensitive and resistant myeloma cells, which led to a significant reduction in cell proliferation and induction of apoptosis, both of which were dependent on ROS. In clonogenic assays, treatment with [Au(d2pype)2]Cl completely abrogated the tumourigenic capacity of MM cells, whereas auranofin was less effective. We also show that [Au(d2pype)2]Cl exerted a significant anti-myeloma activity in vivo in human RPMI8226 xenograft model in immunocompromised NOD/SCID mice. The MYC oncogene, known to drive myeloma progression, was downregulated in both in vitro and in vivo models when treated with [Au(d2pype)2]Cl. This study highlights the “proof of concept” that improved gold(I)-based compounds could potentially be used to not only treat MM but as an alternative tool to understand the role of the Trx system in the pathogenesis of this blood disease." @default.
• W2970639571 created "2019-09-05" @default.
• W2970639571 creator A5000510105 @default.
• W2970639571 creator A5008063221 @default.
• W2970639571 creator A5025783509 @default.
• W2970639571 creator A5042627450 @default.
• W2970639571 creator A5059522957 @default.
• W2970639571 creator A5071621998 @default.
• W2970639571 creator A5080989305 @default.
• W2970639571 creator A5087879253 @default.
• W2970639571 date "2020-01-01" @default.
• W2970639571 modified "2023-10-16" @default.
• W2970639571 title "Anticancer activity of a Gold(I) phosphine thioredoxin reductase inhibitor in multiple myeloma" @default.
• W2970639571 cites W1577036326 @default.
• W2970639571 cites W1878457905 @default.
• W2970639571 cites W1920908631 @default.
• W2970639571 cites W1971155331 @default.
• W2970639571 cites W1972801090 @default.
• W2970639571 cites W1978674137 @default.
• W2970639571 cites W1978735501 @default.
• W2970639571 cites W1978772332 @default.
• W2970639571 cites W1980437676 @default.
• W2970639571 cites W1983823614 @default.
• W2970639571 cites W1985776151 @default.
• W2970639571 cites W1989778625 @default.
• W2970639571 cites W1996311090 @default.
• W2970639571 cites W1998650088 @default.
• W2970639571 cites W2001964759 @default.
• W2970639571 cites W2003675056 @default.
• W2970639571 cites W2009619113 @default.
• W2970639571 cites W2027694461 @default.
• W2970639571 cites W2034207473 @default.
• W2970639571 cites W2038208340 @default.
• W2970639571 cites W2053081724 @default.
• W2970639571 cites W2055502725 @default.
• W2970639571 cites W2055680246 @default.
• W2970639571 cites W2068218660 @default.
• W2970639571 cites W2074966669 @default.
• W2970639571 cites W2077247713 @default.
• W2970639571 cites W2088688594 @default.
• W2970639571 cites W2089927562 @default.
• W2970639571 cites W2095157449 @default.
• W2970639571 cites W2102955022 @default.
• W2970639571 cites W2103289668 @default.
• W2970639571 cites W2114098967 @default.
• W2970639571 cites W2132834292 @default.
• W2970639571 cites W2133401883 @default.
• W2970639571 cites W2140062125 @default.
• W2970639571 cites W2140486627 @default.
• W2970639571 cites W2149659371 @default.
• W2970639571 cites W2154975058 @default.
• W2970639571 cites W2159483734 @default.
• W2970639571 cites W2162180804 @default.
• W2970639571 cites W2207558547 @default.
• W2970639571 cites W2235523093 @default.
• W2970639571 cites W2236153578 @default.
• W2970639571 cites W2238617180 @default.
• W2970639571 cites W2262734805 @default.
• W2970639571 cites W2302330708 @default.
• W2970639571 cites W2415945663 @default.
• W2970639571 cites W2522355820 @default.
• W2970639571 cites W2546459788 @default.
• W2970639571 cites W2549893547 @default.
• W2970639571 cites W2591285760 @default.
• W2970639571 cites W2709224048 @default.
• W2970639571 cites W2785337616 @default.
• W2970639571 cites W2785500009 @default.
• W2970639571 cites W2788354946 @default.
• W2970639571 cites W2802332658 @default.
• W2970639571 cites W2806421539 @default.
• W2970639571 cites W2808324625 @default.
• W2970639571 cites W2935041976 @default.
• W2970639571 cites W77275815 @default.
• W2970639571 cites W904299734 @default.
• W2970639571 doi "https://doi.org/10.1016/j.redox.2019.101310" @default.
• W2970639571 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6742860" @default.
• W2970639571 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31514052" @default.
• W2970639571 hasPublicationYear "2020" @default.
• W2970639571 type Work @default.
• W2970639571 sameAs 2970639571 @default.
• W2970639571 citedByCount "40" @default.
• W2970639571 countsByYear W29706395712020 @default.
• W2970639571 countsByYear W29706395712021 @default.
• W2970639571 countsByYear W29706395712022 @default.
• W2970639571 countsByYear W29706395712023 @default.
• W2970639571 crossrefType "journal-article" @default.
• W2970639571 hasAuthorship W2970639571A5000510105 @default.
• W2970639571 hasAuthorship W2970639571A5008063221 @default.
• W2970639571 hasAuthorship W2970639571A5025783509 @default.
• W2970639571 hasAuthorship W2970639571A5042627450 @default.
• W2970639571 hasAuthorship W2970639571A5059522957 @default.
• W2970639571 hasAuthorship W2970639571A5071621998 @default.
• W2970639571 hasAuthorship W2970639571A5080989305 @default.
• W2970639571 hasAuthorship W2970639571A5087879253 @default.
• W2970639571 hasBestOaLocation W29706395711 @default.
• W2970639571 hasConcept C117262875 @default.
• W2970639571 hasConcept C150903083 @default.
• W2970639571 hasConcept C185592680 @default.

• next